to target and kill deadly brain tumor
Scientists at the School of Medicine have identified a virus that targets and kills glioblastoma, a deadly type of human brain tumor resistant to current medical or surgical treatment, according to a study published as the cover article in the Journal of Virology.
"Malignant glioblastomas are the most common primary brain tumors, causing more than 13,000 deaths each year," says Anthony van den Pol, professor of neurosurgery at the School of Medicine and senior author of the study. "There are currently no known medical or surgical approaches that constitute an effective cure for glioblastoma, and most patients diagnosed with this type of brain tumor live less than a year."
Van den Pol's team put nine different DNA and RNA viruses through a series of tests to determine which infect, slow down or kill brain tumor cells. The researchers then took the viruses that were most effective at killing tumor cells, cultivated viruses for many generations on brain tumor cells, and selected virus clones with improved tumor-killing capacity and reduced capacity to infect non-tumor cells.
The winning candidate was a strain of vesicular stomatitis virus (VSV) that replicates quickly. Whereas humans and other mammals use DNA to carry their genetic code, the viral genome of VSV is encoded by RNA, van den Pol says.
To track the virus as it invaded tumor cells, a recombinant VSV was used that contained a reporter gene isolated from jellyfish that turns infected tumor cells green.
Virus particles that cannot replicate have been used to kill cancer cells, but they can only infect a relatively small number of tumor cells. Van den Pol's group theorized that if the replication-competent virus encounters a tumor cell, it will infect the cell, replicate in the tumor cell, and, as the tumor cells die, more viruses will be released that then target more tumor cells. Van den Pol says the current project is the first stage and more work is needed to ensure the safety of the virus before it can be considered for use in clinical trials.
The first author was Guido Wollmann, postdoctoral associate. Peter Tattersall, professor of genetics and laboratory medicine, was co-author. The study was funded by the National Institutes of Health and the National Cancer Institute.
-- By Jacqueline Weaver
T H I S
W E E K ' SS T O R I E S
Team creates blood test for 'silent killer'
University marks 100 years of 'Pomp and Circumstance'
Yale scientist featured in new stamp series
Twelve honored for strengthening town-gown ties
ENDOWED PROFESSORSHIPSTwo appointed to Sterling chairs
R. Howard Bloch: French and Medieval Studies
Ian Shapiro: Political science and YCIASRomano named Ruebhausen Professor
Waxman is appointed to Flaherty chair
Dr. State has been designated Harris Assistant Professor . . .
Krauss named to second term at Silliman
Researchers discover virus' potential to target and kill deadly brain tumor
Yale professors endow teaching and research fund in the history of science
Study shows, when it comes to fish genitalia, size has pros and cons
Two Yale scientists honored with election to the NAS
Six Yale affiliates elected fellows of scholarly society
Beijing conference explored Chinese constitutionalism
New scholarship will help nurture future activist ministers
Yale-IBM computer facility formally dedicated
REUNIONSAlumni will gather for talks, tours and other special events
Library exhibit celebrates the accomplishments of the Class of '55
Medical school reunions feature talks on cutting-edge research
Yale launches research on lung cancer . . .
Workshop will explore technology's power to capture . . .
Show features artist's colorful depictions of 'Northern Shores'
Glen Micalizio wins Beckman Young Investigator award . . .
IN MEMORIAMBenjamin Mordecai: Drama school teacher and Broadway producer
Memorial service to honor South African historian Leonard Thompson
Campus Notes
Bulletin Home|Visiting on Campus|Calendar of Events|In the News
Bulletin Board|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs|News Releases|
E-Mail Us|Yale Home